AstraZeneca
The Director, R&D QA is a senior leadership role at AstraZeneca responsible for strategy leadership within R&D Quality Assurance, focusing on Process & Systems audit and serving as an extended member of the Audit Leadership Team. The role supports development and delivery of the GxP-regulated, risk-based audit program across R&D functions, suppliers, clinical studies, labs and devices. It is based in Toronto with a hybrid work model (three days in office) and reports to the Executive Director, Audit Quality Assurance.
Headquarters
Cambridge, England, United Kingdom
Company Size
10001+ employees
Founded
1999
Digital Biology is part of AstraZeneca, a global biopharmaceutical company focused on discovering, developing, and commercializing prescription medicines. The Digital Biology organization applies data science, computational biology, AI, and software engineering to accelerate drug discovery and translational research across therapeutic areas.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for AstraZeneca.
Executive Director, Research & Development Quality Assurance (RDQA)
Moderna
Associate Director, Quality Assurance (Clinical Research Preferred)
IQVIA
Associate Director, Audit Management
Vertex
Quality Assurance Manager
CorDx
Associate Director, Quality Assurance (Clinical Research Preferred)
lifelancer
Director, IT Business Partner — R&D & GxP Systems
Beeline Medicines